Omnicell
590 E. Middlefield Road
Mountain View
California
94043
United States
Tel: 650-251-6100
Fax: 650-251-6266
Website: http://www.omnicell.com
About Omnicell
Omnicell pharmacy automation systems help you increase pharmacy staff efficiency, support prevention of medication errors, and provide documentation for regulatory compliance. Our pharmacy systems combine the power of carousel systems and bar code packaging to automate the inventory ordering, receiving, stocking, and picking processes. You'll be assured that the right medications are stocked in the right locations, and that security is maintained for controlled substances.317 articles about Omnicell
-
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
10/11/2022
Omnicell, Inc. today announced the launch of Specialty Pharmacy Services, a turnkey offering with dedicated services to set up, operate, and optimize a specialty pharmacy program.
-
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
9/20/2022
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication management and adherence tools for health systems and pharmacies, held its 2022 Investor Day today and provided an in-depth overview of the Company’s differentiated strategy and unique business model, as well as its Advanced Services portfolio, ESG strategy, and provided more details on its long-term financial targets.
-
Omnicell to Host Investor Day on September 20, 2022
8/25/2022
Omnicell, Inc., a leading provider of medication management and adherence tools for health systems and pharmacies, announced that it will host an Investor Day on September 20, 2022 at 1:00 p.m. Eastern Time.
-
Omnicell Announces Financial Results for Second Quarter 2022
8/4/2022
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2022.
-
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
7/11/2022
Omnicell, Inc. (Nasdaq :OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2022, after market on Thursday, August 4, 2022.
-
Omnicell Announces Financial Results for First Quarter 2022
4/28/2022
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its first quarter ended March 31, 2022.
-
Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
4/5/2022
Omnicell, Inc. will release its financial results for the first quarter 2022, after market on Thursday, April 28, 2022.
-
Omnicell Announces Changes to Its Board of Directors
3/1/2022
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for health systems and pharmacies, announced that Jim Judson and Bruce Smith will not stand for reelection at the Company’s 2022 Annual Meeting of Stockholders.
-
UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes
2/14/2022
Omnicell, Inc. announced that UMC Health System in Lubbock, Texas, has selected Omnicell’s comprehensive portfolio of Advanced Services solutions to support key pharmacy initiatives, including acute care, outpatient, retail, and 340B program strategies.
-
Omnicell Reports Fiscal Year and Fourth Quarter 2021 Results
2/14/2022
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced results for its fourth quarter and fiscal year ended December 31, 2021.
-
Omnicell to Release Fourth-Quarter and Full-Year 2021 Financial Results on February 14, 2022
1/5/2022
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full-year 2021, after market on Monday, February 14, 2022.
-
Omnicell Completes Acquisition of ReCept
12/29/2021
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, has completed the previously announced acquisition of ReCept Holdings, Inc.
-
Omnicell to Acquire ReCept
12/2/2021
Omnicell, Inc. (Nasdaq:OMCL), today announced it has entered into a definitive agreement with ReCept Holdings, Inc., a leading provider of specialty pharmacy management services for health systems, clinics, and physician groups, to acquire its business for total aggregate cash consideration of $100 million, subject to customary adjustments.
-
Omnicell to Present at Upcoming Investor Conferences - Nov 22, 2021
11/22/2021
Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conferences.
-
Omnicell and Fresenius Kabi Collaborate to Enhance Management of Controlled Substances in U.S. Hospitals
11/10/2021
Omnicell, Inc. and pharmacies, and Fresenius Kabi are collaborating to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas.
-
Tucson VA Medical Center Selects Omnicell’s Central Pharmacy Dispensing Service to Enhance Medication Inventory Management
11/2/2021
Omnicell, Inc. today announced that Tucson VA Medical Center has chosen the Company’s Central Dispensing Service (“CPDS”) in an effort to enhance patient safety, improve operational efficiency, and optimize inventory management for its central pharmacy operations.
-
Omnicell Announces Financial Results for Third Quarter 2021
11/2/2021
Omnicell, Inc. today announced results for its third quarter ended September 30, 2021.
-
Omnicell to Release Third Quarter 2021 Financial Results on November 2, 2021
10/11/2021
Omnicell, Inc. will release its financial results for the third quarter of 2021 before the open of the market on Tuesday, November 2, 2021.
-
Omnicell Completes Acquisition of FDS Amplicare
9/9/2021
Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of FDS Amplicare.
-
Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services with Summer 2021 Release
8/18/2021
Omnicell, Inc. today announced its latest enhancements to the Company’s industry-leading portfolio of medication management solutions.